Aquestive Therapeutics
AQST
AQST
97 hedge funds and large institutions have $177M invested in Aquestive Therapeutics in 2024 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
+40
Holders Change %
+70.18%
% of All Funds
1.41%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
51
Increased
23
Reduced
14
Closed
9
Calls
$4.24M
Puts
$1.97M
Net Calls
+$2.27M
Net Calls Change
+$2.02M
Top Buyers
| 1 |
VA
VR Adviser
New York
|
+$23.7M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$9.46M |
| 3 |
LCM
Laurion Capital Management
New York
|
+$6.58M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.77M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$4.26M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$7.93M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$994K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$584K |
| 4 |
Two Sigma Investments
New York
|
-$479K |
| 5 |
Corient Private Wealth
Miami,
Florida
|
-$408K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
6CM
101
683 Capital Management
New York
| – | -$189K | -93,510 | Closed |
|
|
OQS
102
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
| – | -$71.2K | -35,267 | Closed |
|
|
BFM
103
Boothbay Fund Management
New York
| – | -$70.7K | -34,985 | Closed |
|
104
Bank of New York Mellon
New York
| – | -$30K | -14,853 | Closed |
|
|
DBRC
105
D.B. Root & Company
Pittsburgh,
Pennsylvania
| – | -$23.1K | -11,450 | Closed |
|
|
PA
106
Parallel Advisors
San Francisco,
California
| – | -$202 | -100 | Closed |
|